<VariationArchive VariationID="1069632" VariationName="NM_005609.4(PYGM):c.1353dup (p.Ala452fs)" VariationType="Duplication" Accession="VCV001069632" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2021-05-10" MostRecentSubmission="2024-07-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1062406" VariationID="1069632">
      <GeneList>
        <Gene Symbol="PYGM" FullName="glycogen phosphorylase, muscle associated" GeneID="5837" HGNC_ID="HGNC:9726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="64746389" stop="64760715" display_start="64746389" display_stop="64760715" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="64513860" stop="64528186" display_start="64513860" display_stop="64528186" Strand="-" />
          </Location>
          <OMIM>608455</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005609.4(PYGM):c.1353dup (p.Ala452fs)</Name>
      <CanonicalSPDI>NC_000011.10:64753568:G:GG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="64753568" stop="64753569" display_start="64753568" display_stop="64753569" variantLength="1" positionVCF="64753568" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="64521040" stop="64521041" display_start="64521040" display_stop="64521041" variantLength="1" positionVCF="64521040" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>A364fs</ProteinChange>
      <ProteinChange>A452fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.64753569dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.64753569dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.64521041dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.64521041dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013018.1" sequenceAccession="NG_013018" sequenceVersion="1" change="g.12147dup">
            <Expression>NG_013018.1:g.12147dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164716.1" sequenceAccession="NM_001164716" sequenceVersion="1" change="c.1089dup">
            <Expression>NM_001164716.1:c.1089dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001158188.1" sequenceAccession="NP_001158188" sequenceVersion="1" change="p.Ala364fs">
            <Expression>NP_001158188.1:p.Ala364fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005609.4" sequenceAccession="NM_005609" sequenceVersion="4" change="c.1353dup" MANESelect="true">
            <Expression>NM_005609.4:c.1353dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005600.1" sequenceAccession="NP_005600" sequenceVersion="1" change="p.Ala452fs">
            <Expression>NP_005600.1:p.Ala452fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005609.3" sequenceAccession="NM_005609" sequenceVersion="3" change="c.1353dup">
            <Expression>NM_005609.3:c.1353dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="779562449" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005609.4(PYGM):c.1353dup (p.Ala452fs) AND Glycogen storage disease, type V" Accession="RCV001381560" Version="6">
        <ClassifiedConditionList TraitSetID="585">
          <ClassifiedCondition DB="MedGen" ID="C0017924">Glycogen storage disease, type V</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-09" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005609.4(PYGM):c.1353dup (p.Ala452fs) AND Tip-toe gait" Accession="RCV003318688" Version="2">
        <ClassifiedConditionList TraitSetID="45469">
          <ClassifiedCondition DB="MedGen" ID="C0427144">Tip-toe gait</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-01-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-09" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-05-10" MostRecentSubmission="2024-07-29">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="DOI">10.1016/j.rchot.2016.09.001</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="DOI">10.51793/OS.2022.25.6.010</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16786513</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29881221</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34534370</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8316268</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="45469" Type="Finding" ContributesToAggregateClassification="false">
            <Trait ID="32388" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Tip-toe gait</ElementValue>
                <XRef ID="HP:0030051" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Toe walking</ElementValue>
                <XRef ID="HP:0040083" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0427144" DB="MedGen" />
              <XRef Type="primary" ID="HP:0030051" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002394" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0040083" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="585" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2239" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD 5</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">McArdle disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">McArdle type glycogen storage disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscle glycogen phosphorylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myophosphorylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease, type V</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+5/3125" DB="Genetic Alliance" />
                <XRef ID="55912009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GSD V</ElementValue>
                <XRef Type="MIM" ID="232600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">GSD5</ElementValue>
                <XRef Type="MIM" ID="232600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6528" />
                <XRef ID="6528" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Glycogen storage disease type V (GSDV, McArdle disease) is a metabolic myopathy characterized by exercise intolerance manifested by rapid fatigue, myalgia, and cramps in exercising muscles. Symptoms are usually precipitated by isometric exercise or sustained aerobic exercise. Most individuals improve their exercise tolerance by exploiting the "second-wind" phenomenon with relief of myalgia and fatigue after a few minutes of rest. Age of onset is frequently in the first decade of life but can vary; however, diagnosis is typically delayed as myalgia and fatigability are dismissed/overlooked. Fixed muscle weakness occurs in approximately 25% of affected individuals, is more likely to involve proximal muscles, and is more common in individuals of advanced age. Approximately 50% of affected individuals have recurrent episodes of myoglobinuria that can – on occasion – eventually result in acute renal failure.</Attribute>
                <XRef ID="NBK1344" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301518</ID>
                <ID Source="BookShelf">NBK1344</ID>
              </Citation>
              <XRef ID="368" DB="Orphanet" />
              <XRef ID="C0017924" DB="MedGen" />
              <XRef ID="MONDO:0009293" DB="MONDO" />
              <XRef Type="MIM" ID="232600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3105610" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="10702360|MedGen:C0017924" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001580000" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8316268</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16786513</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34534370</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala452Argfs*23) in the PYGM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PYGM are known to be pathogenic (PMID: 8316268, 16786513). This variant is present in population databases (rs779562449, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with McArdle disease (PMID: 34534370). ClinVar contains an entry for this variant (Variation ID: 1069632). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PYGM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.64521040_64521041insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0017924" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7858391" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_005609.4:c.1353dup|OMIM:232600" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004207263" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005609.4:c.1353dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="232600" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7526832" SubmissionDate="2024-06-05" DateLastUpdated="2024-07-29" DateCreated="2023-08-05">
        <ClinVarSubmissionID localKey="PYGM c.1353dup" submittedAssembly="hg38" title="PYGM c.1353dup" />
        <ClinVarAccession Accession="SCV004022487" DateUpdated="2024-07-29" DateCreated="2023-08-05" Type="SCV" Version="2" SubmitterName="Practice for Gait Abnormalities, David Pomarino, Competency Network Toe Walking c/o Practice Pomarino" OrgID="507943" OrganizationCategory="consortium" OrgAbbreviation="Praxis Pomarino" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-10">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">29881221</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="DOI">10.1016/j.rchot.2016.09.001</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="DOI">10.51793/OS.2022.25.6.010</ID>
          </Citation>
          <Comment>Toe Walking has various causes, ranging from idiopathic or habitual reasons to an underlying neuromuscular disease. The most observed form of toe walking is idiopathic toe walking (ITW) - a diagnosis of exclusion. ITW occurs in about 5% of children after their second birthday and is a common problem in pediatric orthopedics. In about 70% of these cases, there is spontaneous remission within six months of the onset of ITW. If the toe walk persists, one can assume the presence of a non-idiopathic form of toe walk (n-ITW). In n-ITW, the causes of the abnormal gait are neurological or myogenic. Differential diagnoses such as infantile cerebral palsy, muscular dystrophy, spinal amyotrophy and hereditary motor-sensory neuropathy as well as rare metabolic disorders of the musculature must be considered (Pomarino et al., 2018). In our clinical ITW consultation, we screen children with n-ITW for a genetic form of tiptoe gait using next generation sequencing for gene variants in 49 genes. These are genes in which gene variants can lead to neuromuscular diseases in which an association with toe-tapping gait has been reported or can be suspected due to patients’ clinical symptoms. To the best of our knowledge, this is the first study in which several patients with toe walking displayed heterozygosity for pathogenic or likely pathogenic PYGM mutations and mild symptoms of the metabolic muscle disease McArdle. The findings of our research are in line with recently published observations in heterozygous family members patients with McArdle disease. We should mention that some of the patients in our cohort harbored heterozygous variants in other genes of our gene panel. However, the numbers in this study were too small to workout any resulting combined genetic effects. It is concluded that genetic conditions can contribute to the development of toe walking. Apparently, even a slight genetic weakening of the muscles can lead to changes to the gait pattern. Future studies must show how the pathomechanism can be explained for the PYGM variants and whether there are new therapeutic approaches to be developed based on this research.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <NamePlatform>Thermo Fisher S5</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>Gene panel analysis</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003307" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001156" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001761" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">limited range of motion of upper ankle</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="rs779562449" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005609.3:c.1353dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0427144" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>PYGM c.1353dup</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7526832" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001156" MappingRef="HP">
        <MedGen CUI="C0221357" Name="Brachydactyly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7526832" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001761" MappingRef="HP">
        <MedGen CUI="C0728829" Name="Pes cavus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3105610" TraitType="Disease" MappingType="XRef" MappingValue="C0017924" MappingRef="MedGen">
        <MedGen CUI="C0017924" Name="Glycogen storage disease, type V" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7526832" TraitType="Disease" MappingType="XRef" MappingValue="C0427144" MappingRef="MedGen">
        <MedGen CUI="C0427144" Name="Tip-toe gait" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7526832" TraitType="Finding" MappingType="Name" MappingValue="limited range of motion of upper ankle" MappingRef="Preferred">
        <MedGen CUI="None" Name="limited range of motion of upper ankle" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7858391" TraitType="Disease" MappingType="XRef" MappingValue="232600" MappingRef="OMIM">
        <MedGen CUI="C0017924" Name="Glycogen storage disease, type V" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7526832" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003307" MappingRef="HP">
        <MedGen CUI="C0024003" Name="Hyperlordosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

